Renascience

Renascience Capital Expenditures

Capital Expenditures (CapEx) of Renascience (4889.T) as of Nov 19, 2026.

Capital Expenditures

0.00JPY

Last updated:

Capital Expenditures (CapEx) of Renascience is 2026 0.00 JPY. Capital Expenditures (CapEx) of Renascience was 2025 -799,000.00 JPY. It decreases by % higher compared to the previous year.

The Renascience Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2020
0.00 JPY
Jan 1, 2021
-1.01 M JPY
Jan 1, 2022
-1.16 M JPY
Jan 1, 2023
-2.23 M JPY
Jan 1, 2024
-1.58 M JPY
Jan 1, 2025
-799,000.00 JPY
Jan 1, 2026
0.00 JPY
The Renascience Capital Expenditures history
YEARCapital ExpendituresYoY
0.00JPY-100.00%
-799,000.00JPY-49.33%
-1.58 MJPY-29.12%
-2.23 MJPY+91.15%
-1.16 MJPY+15.25%
-1.01 MJPY—
0.00JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renascience Stock analysis

What does Renascience do? Renascience, Inc. develops and sells pharmaceuticals, focusing on drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The company collaborates with physicians in research and development of pharmaceuticals, medical devices, and AI solutions for medical problems. Its products target aging-related health issues, including women's and children's diseases and solutions for COVID-19 infection. The firm's revenue comes from the sale of developed pharmaceuticals, medical devices, and AI solutions. Physicians and medical institutions are key buyers of its products, as the company's R&D is conducted in collaboration with them. The primary market segments are aging populations suffering from chronic conditions and healthcare providers seeking innovative medical solutions. Renascience, Inc. operates with a small team of three full-time employees, emphasizing focused R&D on specific medical challenges. Its business model centers on developing targeted therapies for high-impact diseases, leveraging partnerships with physicians to address unmet medical needs in aging-related health conditions. Renascience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renascience stock

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Renascience since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Renascience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Renascience

All Key Metrics — Renascience